扩展主动监测纳入标准:结合术前临床参数与磁共振成像的新列线图
本研究回顾性分析2013至2019年间接受根治性前列腺切除术的1284例低危和中危前列腺癌患者,外部验证Gandaglia风险计算器(Gandaglia-RC)预测不良病理的能力,并评估加入磁共振成像(MRI)发现(MAP模型)是否改善预测。结果显示MAP模型显著提高预测不良病理的AUC(0.71 vs 0.63,p<0.0001),在30%阈值下使更多患者符合主动监测条件(77% vs 45%)而不显著增加不良病理风险(17% vs 16%)。
要点
- MAP模型预测不良病理的AUC为0.71,显著优于Gandaglia-RC的0.63(p<0.0001)。
- 30%阈值下,MAP模型使77%患者符合主动监测,Gandaglia-RC为45%。
- 两模型不良病理风险分别为17%和16%,无显著增加。
核心结论
- 与Gandaglia-RC相比,MAP模型显著增加符合主动监测的患者数量,而不显著增加根治性前列腺切除术后不良病理风险。
研究设计与样本
- 单中心回顾性队列研究,纳入2013至2019年间连续接受根治性前列腺切除术的1284例低危和中危前列腺癌患者。
主要发现
- 多变量分析中,手术年龄、前列腺特异性抗原、系统与靶向活检Gleason分级分组、MRI前列腺体积、PI-RADS评分及MRI包膜外侵犯与不良病理显著相关。
- MAP模型预测不良病理的AUC为0.71,Gandaglia-RC为0.63(p<0.0001)。
- 30%阈值下,Gandaglia-RC和MAP模型符合主动监测的比例分别为45%和77%,不良病理风险分别为16%和17%。
关键数值与推荐
- 不良病理定义为根治性前列腺切除术后非器官局限性疾病和/或淋巴结侵犯和/或病理分级分组≥3。
- 使用30%阈值评估主动监测纳入比例及不良病理风险。
临床怎么用
- MAP模型可用于改善中危前列腺癌患者主动监测的选择,使更多患者安全地接受保守治疗而非手术或放疗。
局限性
- 本研究为单中心回顾性分析,外部验证需多中心前瞻性研究进一步确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current European Association of Urology, American Urological Association, and National Comprehensive Cancer Network guidelines recommend active surveillance (AS) for selected intermediate-risk prostate cancer (PCa) patients. However, limited evidence exists regarding which men can be selected safely. OBJECTIVE: To externally validate the Gandaglia risk calculator (Gandaglia-RC), designed to predict adverse pathology (AP) at radical prostatectomy (RP) and thus able to improve selection of intermediate-risk PCa patients suitable for AS, and to assess whether addition of magnetic resonance imaging (MRI) findings (MAP model) improves the predictive ability of Gandaglia-RC. DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective analysis of a single-center cohort of 1284 consecutive men with low- and intermediate-risk PCa treated with RP between 2013 and 2019. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: AP was defined as non-organ-confined disease and/or lymph node invasion and/or pathological grade group≥3 at RP. Logistic regression was used to calculate the predictors of AP; calculated coefficients were used to develop a risk score. Receiver operating characteristic curve analysis and decision curve analysis were performed to evaluate the net benefit within models. RESULTS AND LIMITATIONS: At multivariable analysis, age at surgery, prostate-specific antigen, systematic and targeted biopsy Gleason grade group, MRI prostate volume, Prostate Imaging Reporting and Data System score, and MRI extraprostatic extension were significantly associated with AP. The model significantly improved the ability of Gandaglia-RC to predict AP (area under the curve 0.71 vs 0.63 [p<0.0001]). Using a 30% threshold, the proportions of men eligible for AS were 45% and 77% and the risks of AP were 16% and 17%, for Gandaglia-RC and MAP model, respectively. CONCLUSIONS: Compared with Gandaglia-RC, the MAP model significantly increased the number of patients eligible for AS without significantly increasing the risk of AP at RP. PATIENT SUMMARY: In this report, we have developed a risk prediction tool to select men for conservative treatment of prostate cancer. Using the novel tool, more men could safely be allocated to conservative treatment rather than surgery or radiation.
引用
- Lantz A, Falagario UG, Ratnani P, et al. Expanding Active Surveillance Inclusion Criteria: A Novel Nomogram Including Preoperative Clinical Parameters and Magnetic Resonance Imaging Findings. Eur Urol Oncol. 2020. PMID: 32891599. doi:10.1016/j.euo.2020.08.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。